# POSIMIR
> **NDA204803** · New Drug Application · Sponsor: INNOCOLL · Approved 2021-02-01
## Drug
- **FDA Application Number:** NDA204803
- **Application type:** New Drug Application
- **Brand name:** POSIMIR
- **Generic name:** Bupivacaine
- **Active ingredients:** BUPIVACAINE
- **Dosage form:** SOLUTION
- **Route:** INFILTRATION
- **Marketing status:** Discontinued
- **Sponsor:** INNOCOLL
- **First approval:** 2021-02-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204803)
---
*MORVS · CC0 1.0*